GUJARAT THEMIS BIOSYN
Back to Cashflow Statement
|
GUJARAT THEMIS BIOSYN Last 5 Year Net Cash Inflow / Outflow History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Cash Inflow / Outflow | ₹5.22 Cr | ₹0.41 Cr | ₹5.79 Cr | ₹-3.51 Cr | ₹3.12 Cr |
What is the latest Net Cash Inflow / Outflow ratio of GUJARAT THEMIS BIOSYN ?
| Year | Net Cash Inflow / Outflow |
|---|---|
| Mar2025 | ₹5.22 Cr |
| Mar2024 | ₹0.41 Cr |
| Mar2023 | ₹5.79 Cr |
| Mar2022 | ₹-3.51 Cr |
| Mar2021 | ₹3.12 Cr |
How is Net Cash Inflow / Outflow of GUJARAT THEMIS BIOSYN Trending?
| Years | Net Cash Inflow / Outflow | % Change | |
|---|---|---|---|
| Mar2025 | ₹5.22 Cr | 1,162.08 | |
| Mar2024 | ₹0.41 Cr | -92.85 | |
| Mar2023 | ₹5.79 Cr | Positive | |
| Mar2022 | ₹-3.51 Cr | Negative | |
| Mar2021 | ₹3.12 Cr | - | |
Compare Net Cash Inflow / Outflow of peers of GUJARAT THEMIS BIOSYN
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GUJARAT THEMIS BIOSYN | ₹4,188.3 Cr | -4.6% | -11.4% | 22.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹449,299.0 Cr | 0.5% | 1.5% | 11.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹174,207.0 Cr | -3.3% | -3.5% | 1.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹157,721.0 Cr | 4.5% | 2.6% | 42.6% | Stock Analytics | |
| CIPLA | ₹117,420.0 Cr | 2.7% | 2.5% | -4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹114,876.0 Cr | 6.6% | 4.3% | 1.9% | Stock Analytics | |
GUJARAT THEMIS BIOSYN Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GUJARAT THEMIS BIOSYN | -4.6% |
-11.4% |
22.3% |
| SENSEX | -0.1% |
1% |
-5.7% |
You may also like the below Video Courses